FDA Withdraws Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products
On Nov. 28, 2025, The Food and Drug Administration (FDA) announced the withdrawal of the proposed rule entitled…
-
-
Artificial Intelligence | Biology | Diagnostics | Disease | Medicine | Pharmaceutical | Therapeutics
MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
-
Artificial Intelligence | Biotechnology | Medical Device | Medicine | Nanotechnology | Neurology | Non-Profit Research | Pharmaceutical | Therapeutics
University at Buffalo to receive $50 million for biofabrication and imaging research hub
On Nov. 25, 2025, Governor Kathy Hochul announced the University at Buffalo (UB) will receive $50 million from…
-
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer
On Nov. 24, 2025, a new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy…
-
New AI model could speed rare disease diagnosis
On Nov. 24, 2025, a new AI model called popEVE developed by Harvard Medical School researchers and colleagues…
-
CDC | Clinical Research | HIV | Infectious Disease | Medicine | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Veterinary
U.S. Centers for Disease Control and Prevention to End Monkey Research Program
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
-
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
-
WHO Reports Diphtheria outbreak in African Region
On Nov. 21, 2025, the World Health Organization (WHO) reported that from 1 January to 2 November 2025,…
-
Agriculture | Artificial Intelligence | Biotechnology | CRISPR | Diagnostics | Environmental | Forestry | Genomics | Infectious Disease | Marine Science | Materials | Nanotechnology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Quantum | Rare Disease | Robotics | Software | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Report Shows How University Research Spending Benefits U.S. Businesses
On Nov. 20, 2025, the Institute for Research on Innovation and Science (IRIS) released a report that demonstrates…
-
Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
-
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
-
CPRIT approves $154 million in new cancer research and prevention awards, surpasses $4 billion total
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
-
Phage Blueprint Reveals New Clues for Combating Drug-Resistant Bacteria
On Nov. 19, 2025, researchers announced a Ōtākou Whakaihu Waka-led study has produced a detailed blueprint of a…
-
Novartis announces plans to build flagship manufacturing hub in North Carolina
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
-
CSL injects $2.3b into US for valuable blood plasma
On Nov. 18, 2025, CSL, Australia’s largest biotech company announced plans to expand its US presence with a…
-
Type 1 diabetes cured in mice with gentle blood stem-cell and pancreatic islet transplant
On Nov. 18, 2025, Stanford Medicine researchers reported that a combination blood stem cell and pancreatic islet cell…
-
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
-
Biotechnology | Disease | FDA | Therapeutics
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
On Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
-
CRISPR breakthrough reverses chemotherapy resistance in lung cancer
On Nov. 17, 2025, in a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute…
-
Agriculture | Artificial Intelligence | Biotechnology | Chemistry | Clinical Research | Diagnostics | Energy | Environmental | Infectious Disease | Marine Science | Medical Device | Nanotechnology | Neurology | NIH | Non-Profit Research | Rare Disease | Therapeutics | Vaccine | Women's Health
NIH funding cuts have impacted more than 74,000 people enrolled in trials
On Nov. 17, 2025, a JAMA published study found that more than 74,000 people have had their lives…
-
Merck to Acquire Cidara Therapeutics for $9.2 Billion, Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
On Nov. 14, 2025, Merck and Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, announced that…
-
Ethiopia reports suspected viral haemorrhagic fever outbreak
On Nov. 13, 2025, the World Health Organization (WHO) reported that Health authorities in Ethiopia are carrying out…
-
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
On Nov. 13, 2025, Legend Biotech announced the official opening and ribbon cutting of its new, state-of-the-art research…
-
FDA Quietly Approves Denosumab Biosimilars, Issues Interchangeability for Others
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
-
Scientists unveil the world’s most comprehensive AI-powered tool for neuroscience: Brain Knowledge Platform
On Nov. 12, 2025, Allen Institute researchers and engineers have unlocked an the world’s most comprehensive AI-powered tool…
-
Biotechnology | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine | Women's Health
Stanford Medicine scientists tie lupus to a virus nearly all of us carry
On Nov. 12, 2025, Stanford Medicine scientists have found that the Epstein-Barr virus can convert B cells it’s…
-
Animal testing to be phased out faster as UK unveils roadmap for alternative methods
On Nov. 11, 2025, the United Kingdom government announced that animal testing in science is set to be…
-
Artificial Intelligence | Biotechnology | Energy | Environmental | Forestry | Genomics | Infectious Disease | Nanotechnology | Neurology | Oncology | Pharmaceutical | Therapeutics | Vaccine
China’s new scientist visa is a ‘serious bid’ for the world’s top talent
On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
-
Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children
On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…
-
FDA reverses decades-old warning on hormone therapy products for menopause
On Nov. 10, 2025, the Food and Drug Administration (FDA) is reversing a 2003 decision that put a…
